AGI Announces Second Quarter 2025 Results and Reiterates Full Year Outlook
31 juli, 23:00
31 juli, 23:00
Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we”, or “our”) today announced its financial results for the three-month period ending June 30, 2025 and reiterated its previously stated outlook for full year 2025 Adjusted EBITDA.
Second Quarter 2025 Highlights
Outlook
“Our second quarter results reflect the continued strength of our international Commercial business, particularly in Brazil and EMEA4,” said Paul Householder, President and CEO of AGI. “While the North American Farm market remains soft, our diversification strategy and execution of long-term projects internationally have enabled us to deliver second quarter results towards the high-end of expectations. Our expanded capabilities that enable us to take on larger and more comprehensive projects has elevated enthusiasm about the potential of our international Commercial segment. Overall, with year-over-year revenue stabilizing in the second quarter, and significant strength in our Commercial order book, we anticipate returning to top-line growth in the second half of 2025. The outlook for the full year remains consistent though it has been updated to reflect additional strength in Commercial offset by continued softness in Farm, netting-out to unchanged full year Adjusted EBITDA guidance levels.”
“Amid the exciting opportunities in our international Commercial segment, we remain cognizant of the balance sheet and working capital implications,” said Jim Rudyk, CFO of AGI. “We are advancing structures to monetize receivables connected to our international Commercial projects which we expect to meaningfully reduce our working capital position and our net debt leverage ratio by year end. We are progressing through the usual process and steps to set up these kinds of arrangements and are targeting to finalize them in the third quarter. We’d like to thank all our partners for the support and cooperation to help make these significant projects a reality.”
1 Historical or forward-looking non-IFRS financial measure. See “Non-IFRS and Other Financial Measures”. |
- Second quarter 2025 profit before income taxes of $36.6 million. |
- Cash provided by operating activities of $30.7 million for LTM ended June 30, 2025. |
- Adjusted EBITDA for the year ended December 31, 2024 was $265 million. |
2 Historical or forward-looking non-IFRS ratio. See “Non-IFRS and Other Financial Measures”. |
3 Supplementary financial measure. See "Non-IFRS and Other Financial Measures". |
4 Europe, Middle East and Africa. |
SUMMARY OF SECOND QUARTER 2025 RESULTS
Revenue by Operating Segment | Three-months ended June 30 | |||
2025 | 2024 | Change | Change | |
[thousands of dollars except percentages] | $ | $ | $ | % |
Revenue[1] | ||||
Farm | 126,825 | 194,455 | (67,630) | (35%) |
Commercial | 221,735 | 157,326 | 64,409 | 41% |
Total | 348,560 | 351,781 | (3,221) | (1%) |
Adjusted EBITDA by Operating Segment | Three-months ended June 30 | |||
2025 | 2024 | Change | Change | |
[thousands of dollars except percentages] | $ | $ | $ | % |
Adjusted EBITDA[2] | ||||
Farm | 29,297 | 53,236 | (23,939) | (45%) |
Commercial | 36,803 | 23,248 | 13,555 | 58% |
Other [3] | (11,856) | (8,442) | (3,414) | N/A |
Total | 54,244 | 68,042 | (13,798) | (20%) |
Adjusted EBITDA Margin % by | Three-months ended June 30 | |||
2025 | 2024 | Change | Change | |
% | % | basis points | % | |
Adjusted EBITDA Margin % [2] | ||||
Farm | 23.1% | 27.4% | (428) bps | (16%) |
Commercial | 16.6% | 14.8% | 182 bps | 12% |
Other [3] | (3.4%) | (2.4%) | (100) bps | N/A |
Consolidated | 15.6% | 19.3% | (378) bps | (20%) |
Revenue by Geography [1] | Three-months ended June 30 | |||
[thousands of dollars except percentages] | 2025 | 2024 | Change | Change |
$ | $ | $ | % | |
Canada | 65,450 | 94,364 | (28,914) | (31%) |
U.S. | 112,824 | 146,366 | (33,542) | (23%) |
International | 170,286 | 111,051 | 59,235 | 53% |
Total Revenue | 348,560 | 351,781 | (3,221) | (1%) |
[1] | Supplementary financial measure. See "Non-IFRS and Other Financial Measures". | |
[2] | Non-IFRS financial measure or non-IFRS ratio. See "Non-IFRS and Other Financial Measures". | |
[3] | Included in Other is the corporate office, which is not a reportable segment, and which provides finance, treasury, legal, human resources and other administrative support to the segments and geographical regions, as applicable. The Adjusted EBITDA Margin % for Other is calculated based on total revenue since it does not generate revenue without the segments. | |
Order book
The following table presents YOY changes in the Company’s order book[1] as at June 30, 2025:
As at June 30 | ||||
[thousands of dollars except percentages] | 2025 | 2024[2] | Change | Change |
$ | $ | $ | % | |
Order book | 659,809 | 632,389 | 27,420 | 4% |
[1] | Supplementary financial measure. See "Non-IFRS and Other Financial Measures". | |
[2] | The order book as at June 30, 2024 has been revised to reflect orders that were outstanding at June 30, 2024 but that were subsequently cancelled. AGI originally reported an order book as at June 30, 2024 of $651 million. Revisions of this nature occur from time-to-time as part of normal business operations. | |
Second Quarter Farm Segment Summary
As anticipated, challenging conditions persisted across our Farm segment. U.S. and Canada, in particular, continue to face soft farmer demand given commodity prices below long-term averages as well as elevated dealer channel inventory levels which have yet to fully decline. These factors are compounded by shifting tariff policies and government subsidy uncertainty which create additional cautiousness across the entire farm equipment sector. Overall, Adjusted EBITDA Margin % remains compressed in the Farm segment relative to last year primarily due to lower volumes and, to a lesser extent, tariffs. Looking ahead, we anticipate near-term uncertainty for the North American Farm market to remain into the second half of 2025.
Second Quarter Commercial Segment Summary
Several long-term projects in our international regions in addition to stable U.S. activity drove strong growth across the Commercial segment. Brazil continues to successfully progress several large and comprehensive projects won in the second half of 2024 and the first half of 2025. The scale of the projects we are winning and the overall momentum in our international Commercial business highlight the broadening of our differentiated capabilities. Enabled by our product transfer program, we are able to deliver on nearly every aspect of these projects including a full scope of engineering, design, equipment supply, and installation services. Several notable projects won in the second quarter, in addition to a highly active quoting pipeline, create a solid outlook for continued momentum in our Commercial segment for the second half of the year and into early 2026.
MD&A and Financial Statements
AGI's unaudited interim condensed consolidated financial statements ("consolidated financial statements") and management’s discussion and analysis (the “MD&A”) for the three- and six-month periods ended June 30, 2025 can be obtained electronically on SEDAR+ (www.sedarplus.ca) and on AGI's website (www.aggrowth.com).
Conference Call
AGI will hold a conference call on Friday, August 1, 2025, at 8:00am ET to discuss its results for the three- and six-months ending June 30, 2025. To attend the event, please join using the AGI Second Quarter Results webcast link. Alternatively, participants can dial-in using +1-833-821-0159 if calling from Canada or the U.S. and +1-647-846-2271 internationally.
A replay of the webcast will be made available on AGI’s website. In addition, an audio replay of the call will be available for seven days. To access the audio replay, please dial +1-855-669-9658 if calling from Canada or the U.S. and +1-412-317-0088 internationally. Please enter access code 1863266# for the audio replay.
AGI Company Profile
AGI is a provider of the equipment and solutions required to support the efficient storage, transport, and processing of food globally. AGI has manufacturing facilities in Canada, the United States, Brazil, India, France, and Italy and distributes its product worldwide.
Further information can be found in the disclosure documents filed by AGI with the securities regulatory authorities, available at www.sedarplus.ca and on AGI's website www.aggrowth.com.
NON-IFRS AND OTHER FINANCIAL MEASURES
This press release makes reference to certain specified financial measures, including non-IFRS financial measures, non-IFRS ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing our business performance and trends. These specified financial measures are not recognized measures under International Financial Reporting Standards (“IFRS”), do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement our financial information reported under IFRS by providing further understanding of our results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS.
We use the following (i) non-IFRS financial measures: “adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”)”, “free cash flow” and “net debt”; (ii) non-IFRS ratios: “Adjusted EBITDA margin %” and “net debt leverage ratio”; and (iii) supplementary financial measures: “order book”, “revenue by operating segment” and “revenue by geography”; to provide supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS financial measures, non-IFRS ratios and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. We strongly encourage investors to review our consolidated financial statements and publicly filed reports in their entirety and not to rely on any single financial measure or ratio.
We use these specified financial measures in addition to, and in conjunction with, results presented in accordance with IFRS. These specified financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our IFRS results and, in the case of non-IFRS financial measures, the accompanying reconciliations to the most directly comparable IFRS financial measures, may provide a more complete understanding of factors and trends affecting our business.
In this press release, we discuss the specified financial measures, including the reasons that we believe that these measures provide useful information regarding our financial condition, results of operations, cash flows and financial position, as applicable, and, to the extent material, the additional purposes, if any, for which these measures are used. Reconciliations of non-IFRS financial measures to the most directly comparable IFRS financial measures are contained in this press release.
The following is a list of non-IFRS financial measures, non-IFRS ratios and supplementary financial measures that are referenced throughout this press release:
“Adjusted EBITDA” is defined as income (loss) before income taxes before finance costs, depreciation and amortization, share of associate’s net income (loss), gain or loss on foreign exchange, non-cash share-based compensation expenses, net gain or loss on financial instruments, transaction, transitional and other costs (recovery), Enterprise Resource Planning system transformation costs, net gain or loss on sale of long-lived assets, equipment rework and remediation, accounts receivable reserve (recovery) for the conflict between Russia and Ukraine, and impairment charge (recovery). Adjusted EBITDA is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is profit (loss) before income taxes. Management believes Adjusted EBITDA is a useful measure to assess the performance and cash flow of the Company as it excludes the effects of interest, taxes, depreciation, amortization and expenses that management believes are not reflective of the Company’s underlying business performance. Management cautions investors that Adjusted EBITDA should not replace profit or loss as indicators of performance, or cash flows from operating, investing, and financing activities as a measure of the Company’s liquidity and cash flows. See “Profit (loss) before income taxes and Adjusted EBITDA” and “Profit (loss) before income taxes and Adjusted EBITDA by Operating Segment” below for the reconciliation of Adjusted EBITDA to profit (loss) before income taxes for the relevant periods. Adjusted EBITDA guidance is a forward-looking non-IFRS financial measure. We do not provide a reconciliation of such forward-looking measure to the most directly comparable financial measure calculated and presented in accordance with IFRS due to unknown variables and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. Guidance for Adjusted EBITDA is calculated in the same manner as described above for historical Adjusted EBITDA, as applicable.
“Adjusted EBITDA margin %” is defined as Adjusted EBITDA divided by revenue. Adjusted EBITDA margin % is a non-IFRS ratio because one of its components, Adjusted EBITDA, is a non-IFRS financial measure. Management believes Adjusted EBITDA margin % is a useful measure to assess the performance and cash flow of the Company.
“Free cash flow” is defined as cash provided (used) by operating activities less acquisition of property, plant and equipment and less development and purchase of intangible assets. Free cash flow is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is cash provided (used) by operating activities. Management believes that free cash flow provides useful information about the Company’s ability to generate available cash that can be used to fund ongoing and prospective strategic initiatives, reduce debt, or pursue other initiatives to enhance shareholder value after investing in capital expenditures that are required to maintain and grow the Company. Management uses free cash flow to help monitor the operational efficiency and financial flexibility of the Company. See “Free Cash Flow” below for a reconciliation of free cash flow to cash provided (used) by operating activities for the relevant periods.
“Order book” is defined as the total value of committed sales orders that have not yet been fulfilled that: (a) have a high certainty of being performed as a result of the existence of a purchase order, an executed contract or work order specifying job scope, value and timing; or (b) has been awarded to the Company or its divisions, as evidenced by an executed binding letter of intent or agreement, describing the general job scope, value and timing of such work, and where the finalization of a formal contract in respect of such work is reasonably assured. Order book is a supplementary financial measure.
“Revenue by Operating Segment” and “Revenue by Geography”: The revenue information presented under “Revenue by Operating Segment” and “Revenue by Geography” are supplementary financial measures used to present the Company’s revenue by segment and geography.
“Net Debt Leverage Ratio” is a non-IFRS ratio and is defined as net debt divided by Adjusted EBITDA for the last twelve-month (“LTM”) period. Net debt leverage ratio is a non-IFRS ratio because its components, net debt and Adjusted EBITDA, are non-IFRS financial measures. Management believes net debt leverage ratio is a useful measure to assess AGI’s leverage position.
“Net Debt” is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is long-term debt. Net debt is defined as the sum of long-term debt, convertible unsecured subordinated debentures, senior unsecured subordinated debentures, and lease liabilities less cash and cash equivalents. Management believes that net debt is a useful measure to evaluate AGI’s capital structure and to provide a measurement of AGI’s total indebtedness. See “Net Debt” below for a reconciliation of long-term debt to net debt for the relevant periods.
Profit (loss) before income taxes and Adjusted EBITDA
The following table reconciles profit (loss) before income taxes to Adjusted EBITDA.
Year ended December 31 | ||
[thousands of dollars] | 2024 | 2023 |
$ | $ | |
Profit (loss) before income taxes | (5,326) | 86,067 |
Finance costs | 70,242 | 73,667 |
Depreciation and amortization | 70,798 | 65,316 |
Share of associate's net income [1] | (109) | — |
Loss (gain) on foreign exchange [2] | 43,119 | (7,571) |
Share-based compensation [3] | 13,758 | 12,159 |
Net gain on financial instruments [4] | (3,812) | (5,369) |
Transaction, transitional and other costs [5] | 56,148 | 27,174 |
Enterprise Resource Planning (“ERP”) system transformation costs [6] | 17,271 | 14,001 |
Net loss on sale of long-lived assets [7] | 23 | 454 |
Equipment rework and remediation | — | 24,108 |
Accounts receivable reserve (recovery) for RUK | (268) | 1,651 |
Impairment charge [8] | 2,944 | 2,237 |
Adjusted EBITDA [9] | 264,788 | 293,894 |
[1] | See “Note 7 – Brazil investments” in our audited annual consolidated financial statements for the years ended December 31, 2024 and 2023 (the “2024 consolidated financial statements” and “2023 consolidated financial statements”). | |
[2] | See “Note 25[e] – Finance expenses (income)” in our 2024 consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 24 – Share-based compensation plans” in our 2024 consolidated financial statements. | |
[4] | See “Equity swap” in “Note 30 – Financial instruments and financial risk management” in our 2024 consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations, and other acquisition related transition costs as well as the accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | See “Note 11 – Property, plant and equipment” and “Note 16 – Assets held for sale” in our 2024 consolidated financial statements. | |
[8] | See “Impairment charge” in our 2024 consolidated financial statements. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Three-months ended June 30 | Six-months ended June 30 | |||
[thousands of dollars] | 2025 | 2024 | 2025 | 2024 |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 36,646 | (7,650) | 20,075 | (3,801) |
Finance costs | 17,213 | 17,060 | 33,806 | 36,011 |
Depreciation and amortization | 16,251 | 18,306 | 33,510 | 35,451 |
Share of associate's net income [1] | (640) | — | (498) | — |
Loss (gain) on foreign exchange [2] | (13,718) | 13,791 | (14,911) | 19,209 |
Share-based compensation [3] | 3,558 | 2,768 | 5,560 | 7,184 |
Net loss (gain) on financial instruments [4] | (3,181) | 3,812 | 3,426 | (4,004) |
Transaction, transitional and other costs (recovery) [5] | (6,284) | 11,929 | (2,567) | 16,379 |
ERP system transformation costs [6] | 4,208 | 4,925 | 7,005 | 9,050 |
Net loss (gain) on sale of long-lived assets [7] | 88 | 10 | 80 | (196) |
Accounts receivable recovery for RUK | — | — | — | (268) |
Impairment charge | 103 | 3,091 | 23 | 3,091 |
Adjusted EBITDA [8] | 54,244 | 68,042 | 85,509 | 118,106 |
[1] | See “Note 6 – Brazil investments” in our consolidated financial statements. | |
[2] | See “Note 13[e] – Finance expense (income)” in our consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 12 – Share-based compensation plans” in our consolidated financial statements. | |
[4] | See “Equity swap” in our consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. | |
[8] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Last Twelve-months ended June 30 | ||
[thousands of dollars] | 2025 | 2024 |
$ | $ | |
Profit (loss) before income taxes | 18,550 | 42,572 |
Finance costs | 68,037 | 73,660 |
Depreciation and amortization | 68,857 | 68,296 |
Share of associate’s net income [1] | (607) | — |
Loss on foreign exchange [2] | 8,692 | 20,788 |
Share-based compensation [3] | 12,134 | 13,037 |
Net loss (gain) on financial instruments [4] | 3,618 | (4,353) |
Transaction, transitional and other costs [5] | 37,202 | 30,829 |
ERP system transformation costs [6] | 15,226 | 23,051 |
Net loss on sale of long-lived assets [7] | 299 | 47 |
Remediation and rework | — | 3,600 |
Accounts receivable recovery for RUK | — | (350) |
Foreign exchange reclassification on disposal of foreign operation | 307 | — |
Impairment charge (recovery) [8] | (124) | 4,537 |
Adjusted EBITDA [9] | 232,191 | 275,714 |
[1] | See “Brazil Investments” in our consolidated financial statements and in our 2024 and 2023 consolidated financial statements. | |
[2] | See “Finance expenses (income)” in our consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Share-based compensation plans” in our consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[4] | See “Equity swap” in our consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations, and other acquisition related transition costs as well as the accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. See “Property, plant and equipment” and “Assets held for sale” in our 2024 and 2023 consolidated financial statements. | |
[8] | See “Impairment charge” in our 2024 and 2023 consolidated financial statements. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Last Twelve-months ended March 31 | ||
[thousands of dollars] | 2025 | 2024 |
$ | $ | |
Profit (loss) before income taxes | (25,746) | 68,290 |
Finance costs | 67,884 | 74,937 |
Depreciation and amortization | 70,912 | 66,421 |
Share of associate’s net loss [1] | 33 | — |
Loss on foreign exchange [2] | 36,508 | 464 |
Share-based compensation [3] | 11,344 | 12,307 |
Net loss on financial instruments [4] | 10,611 | 19 |
Transaction, transitional and other costs [5] | 55,415 | 27,695 |
ERP system transformation costs [6] | 15,943 | 18,126 |
Net loss on sale of long-lived assets [7] | 221 | 49 |
Remediation and rework | — | 24,108 |
Accounts receivable reserve for RUK | — | 1,383 |
Impairment charge [8] | 2,864 | 2,047 |
Adjusted EBITDA [9] | 245,989 | 295,846 |
[1] | See “Brazil Investments” in our unaudited interim condensed consolidated financial statements for the three-month period ended March 31, 2025 (the “2025 Q1 consolidated financial statements”) and in our 2024 consolidated financial statements. | |
[2] | See “Finance expenses (income)” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Share-based compensation plans” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[4] | See “Equity swap” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations, and other acquisition related transition costs as well as the accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. See “Property, plant and equipment” and “Assets held for sale” in our 2024 and 2023 consolidated financial statements. | |
[8] | See “Impairment charge” in our 2024 and 2023 consolidated financial statements. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Profit (loss) before income taxes and Adjusted EBITDA by Operating Segment
The following tables reconcile profit (loss) before income taxes to Adjusted EBITDA by operating segment for the applicable periods.
Three-months ended June 30, 2025 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 22,329 | 29,812 | (15,495) | 36,646 |
Finance costs | — | — | 17,213 | 17,213 |
Depreciation and amortization [1] | 6,475 | 7,640 | 2,136 | 16,251 |
Share of associate's net income [2] | — | (640) | — | (640) |
Gain on foreign exchange [3] | — | — | (13,718) | (13,718) |
Share-based compensation [4] | — | — | 3,558 | 3,558 |
Net gain on financial instruments [5] | — | — | (3,181) | (3,181) |
Transaction, transitional and other costs (recovery) [6] | 428 | — | (6,712) | (6,284) |
ERP system transformation costs [7] | — | — | 4,208 | 4,208 |
Net loss (gain) on sale of long-lived assets [1] [8] | (38) | (9) | 135 | 88 |
Impairment charge | 103 | — | — | 103 |
Adjusted EBITDA [9] | 29,297 | 36,803 | (11,856) | 54,244 |
Three-months ended June 30, 2024 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 38,193 | 14,910 | (60,753) | (7,650) |
Finance costs | — | — | 17,060 | 17,060 |
Depreciation and amortization [1] | 7,889 | 8,581 | 1,836 | 18,306 |
Loss on foreign exchange [3] | — | — | 13,791 | 13,791 |
Share-based compensation [4] | — | — | 2,768 | 2,768 |
Net loss on financial instruments [5] | — | — | 3,812 | 3,812 |
Transaction, transitional and other costs [6] | 3,785 | — | 8,144 | 11,929 |
ERP system transformation costs [7] | — | — | 4,925 | 4,925 |
Net loss (gain) on sale of long-lived assets [1] [8] | 355 | (320) | (25) | 10 |
Impairment charge | 3,014 | 77 | — | 3,091 |
Adjusted EBITDA [9] | 53,236 | 23,248 | (8,442) | 68,042 |
Six-months ended June 30, 2025 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 32,884 | 46,304 | (59,113) | 20,075 |
Finance costs | — | — | 33,806 | 33,806 |
Depreciation and amortization [1] | 13,981 | 15,505 | 4,024 | 33,510 |
Share of associate's net income [2] | — | (498) | — | (498) |
Gain on foreign exchange [3] | — | — | (14,911) | (14,911) |
Share-based compensation [4] | — | — | 5,560 | 5,560 |
Net loss on financial instruments [5] | — | — | 3,426 | 3,426 |
Transaction, transitional and other costs (recovery) [6] | 1,607 | — | (4,174) | (2,567) |
ERP system transformation costs [7] | — | — | 7,005 | 7,005 |
Net loss (gain) on sale of long-lived assets [1] [8] | (21) | (22) | 123 | 80 |
Impairment charge | 23 | — | — | 23 |
Adjusted EBITDA [9] | 48,474 | 61,289 | (24,254) | 85,509 |
Six-months ended June 30, 2024 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 76,451 | 20,064 | (100,316) | (3,801) |
Finance costs | — | — | 36,011 | 36,011 |
Depreciation and amortization [1] | 14,853 | 16,907 | 3,691 | 35,451 |
Loss on foreign exchange [3] | — | — | 19,209 | 19,209 |
Share-based compensation [4] | — | — | 7,184 | 7,184 |
Net gain on financial instruments [5] | — | — | (4,004) | (4,004) |
Transaction, transitional and other costs [6] | 3,785 | — | 12,594 | 16,379 |
ERP system transformation costs [7] | — | — | 9,050 | 9,050 |
Net loss (gain) on sale of long-lived assets [1] [8] | 141 | (314) | (23) | (196) |
Accounts receivable recovery for RUK | — | (268) | — | (268) |
Impairment charge | 3,014 | 77 | — | 3,091 |
Adjusted EBITDA [9] | 98,244 | 36,466 | (16,604) | 118,106 |
[1] | Allocated based on the segment of the underlying asset’s cash generating unit (“CGU”). | |
[2] | See “Note 6 – Brazil investments” in our consolidated financial statements. | |
[3] | See “Note 13[e] – Finance expense (income)” in our consolidated financial statements. | |
[4] | The Company’s share-based compensation expense pertains to our EIAP and DDCP. See “Note 12 – Share-based compensation plans” in our consolidated financial statements. | |
[5] | See “Equity swap” in our consolidated financial statements. | |
[6] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. | |
[7] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[8] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
[10] | Included in Other is the corporate office, which is not a reportable segment, and which provides finance, treasury, legal, human resources and other administrative support to the segments. | |
Net Debt
The following table reconciles long term debt to net debt as at June 30, 2025 and 2024 and March 31, 2025.
Q2/25 | Q1/25 | Q2/24 | |
[thousands of dollars] | 30-Jun-25 | 31-Mar-25 | 30-Jun-24 |
Long Term Debt | 528,785 | 639,896 | 523,727 |
Convertible Unsecured Subordinated Debentures | 200,688 | 198,837 | 193,479 |
Senior Unsecured Subordinated Debentures | 177,392 | 84,085 | 169,559 |
Leases | 45,224 | 46,705 | 46,054 |
Less: Cash & Cash Equivalents | 47,527 | 76,951 | 85,909 |
Net Debt | 904,562 | 892,572 | 846,910 |
Free Cash Flow
The following table reconciles cash provided (used) by operating activities to free cash flow for the applicable periods.
Last Twelve-months ended June 30 | ||
2025 | 2024 | |
[thousands of dollars] | $ | $ |
Cash provided by operating activities | 30,737 | 118,510 |
Less: acquisition of property, plant and equipment | (20,110) | (44,970) |
Less: development and acquisition of intangibles | (10,293) | (8,681) |
Free cash flow [1] | 334 | 64,859 |
[1] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure | |
FORWARD-LOOKING INFORMATION
This press release contains forward-looking statements and information [collectively, “forward-looking information”] within the meaning of applicable securities laws that reflect our expectations regarding the future growth, results of operations, performance, business prospects, and opportunities of the Company. All information and statements contained herein that are not clearly historical in nature constitute forward-looking information, and the words “anticipate”, “estimate”, “believe”, “continue”, “could”, “expects”, “intend”, “trend”, “plans”, “will”, “may” or similar expressions suggesting future conditions or events or the negative of these terms are generally intended to identify forward-looking information. Forward-looking information involves known or unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. In addition, this press release may contain forward-looking information attributed to third party industry sources. Undue reliance should not be placed on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which it is based will occur. In particular, the forward-looking information in this press release includes information relating to: our Adjusted EBITDA guidance for full year 2025; our belief that the increase in our order book is supported by significant growth within our international Commercial businesses; our belief that our current Commercial order book is strong and provides visibility for the remainder of 2025; our belief that Farm segment visibility for the second half of 2025 remains limited due to challenging market conditions; that based on current tariff policies and regulations, we estimate a relatively minor direct cost impact to AGI in 2025; our beliefs regarding the continued strength of our international Commercial business, particularly in Brazil and EMEA; our beliefs that our expanded capabilities enable us to take-on larger and more comprehensive projects and has elevated enthusiasm about the potential of our international Commercial segment; our expectations that we will return to top-line growth across the second half of 2025 as a result of year-over-year revenue stabilizing across Q2, and significant strength in our Commercial order book; our beliefs regarding our overall outlook for full year 2025; our expectations that we will be able to meaningfully reduce our working capital position and our leverage ratio; our expectations regarding the challenging conditions in our Farm segment, particularly in the U.S. and Canada, with respect to soft farmer demand given commodity prices below long-term averages putting pressure on farmer income, and elevated dealer inventory levels; our expectations regarding Adjusted EBITDA Margin % in the Farm segment; our expectations that near-term uncertainty for the North American Farm market to remain into the second half of the year; our expectations regarding several large and comprehensive projects in Brazil, including that such project wins underscore the broadening of our capabilities to be able to execute the construction of comprehensive and dynamic facilities; our belief that we are able to deliver on nearly every aspect of these projects including a full scope of engineering, design, equipment supply, and installation services; and our expectations regarding the overall momentum in our international Commercial business.
Such forward-looking information reflects our current beliefs and is based on information currently available to us, including certain key expectations and assumptions concerning: the duration and impact of tariffs that are currently in effect on goods exported from or imported into Canada, and that other than the tariffs that are currently in effect, neither the U.S., China nor Canada (i) increases the rate or scope of such tariffs, reenacts tariffs that are currently suspended, or imposes new tariffs, on the import of goods from one country to the other, including on the products that AGI imports or exports and/or (ii) imposes any other form of tax, restriction, or prohibition on the import or export of products from one country to the other, including on the products that AGI imports or exports; anticipated crop yields and production in our market areas; the financial and operating attributes of acquired businesses and the anticipated future performance thereof; the value of acquired businesses and assets and the liabilities assumed (and indemnities provided) by AGI in connection therewith; anticipated financial performance; future debt levels; business prospects and strategies, including the success of our operational excellence initiatives; product and input pricing; the scope, nature, timing and cost of re-supplying certain equipment and re-completing certain work that has previously been supplied or completed pursuant to warranty obligations or otherwise; regulatory developments; tax laws; the sufficiency of budgeted capital expenditures in carrying out planned activities; currency exchange rates, inflation rates and interest rates; the cost of materials, labour and services and the impact of inflation rates and/or supply chain disruptions and/or labour activity thereon; the impact of competition; the general stability of the economic and regulatory environments in which the Company operates; the timely receipt of any required regulatory and third party approvals; the ability of the Company to obtain and retain qualified staff and services in a timely and cost efficient manner; the amount and timing of the dividends that we expect to pay; the amount of funds that we expect to invest in the repurchase of our common shares under our normal course issuer bid and the timing thereof; the ability of the Company to obtain financing on acceptable terms; the regulatory framework in the jurisdictions in which the Company operates; the ability of the Company to successfully market its products and services; and that a pandemic or other public health emergency will not have a material impact on our business, operations, and financial results going forward.
Forward-looking information involves significant risks and uncertainties. A number of factors could cause actual results to differ materially from results discussed in the forward-looking information. These risks and uncertainties include but are not limited to the following: the risk that (i) the tariffs that are currently in effect on goods exported from or imported into Canada continue in effect for an extended period of time, the tariffs that have been threatened are implemented, that tariffs that are currently suspended are reactivated, the rate or scope of existing tariffs are increased or expanded, or new tariffs are imposed, including on products that AGI exports or imports, (ii) the U.S., China and/or Canada imposes any other form of tax, restriction or prohibition on the import or export of products from one country to the other, including on products that AGI exports or imports, and (iii) the tariffs imposed or threatened to be imposed by the U.S. on other countries and retaliatory tariffs imposed or threatened to be imposed by other countries on the U.S., will trigger a broader global trade war which could have a material adverse effect on the Canadian, U.S. and global economies, and by extension the Canadian, U.S. and international agricultural industry and AGI, including by decreasing demand for (and the price of) AGI’s products, disrupting supply chains, increasing costs, causing volatility in global financial markets, and limiting access to financing; general economic and business conditions and changes in international, national and local macroeconomic and business conditions, as well as sociopolitical conditions in certain local or regional markets, including as a result of conflicts in the Middle East and the conflict between Russia and Ukraine and the responses thereto from other countries and institutions (including trade sanctions and financial controls), which has created volatility in the global economy and could continue to adversely impact economic and trade activity; the effects of global outbreaks of pandemics or contagious diseases or the fear of such outbreaks, such as the coronavirus (COVID-19) pandemic; the ability of management to execute the Company’s business plan; fluctuations in agricultural and other commodity prices, interest rates, inflation rates and currency exchange rates; crop planting, crop conditions and crop yields; weather patterns; the timing of harvest and conditions during harvest; volatility of production costs, including the risk of production cost increases that may arise as a result of inflation and/or supply chain disruptions and/or labour actions, and the risk that we may not be able to pass along all or any portion of increased costs to customers; governmental regulation of the agriculture and manufacturing industries, including environmental and climate change regulation; actions taken by governmental authorities, including increases in taxes, changes in government regulations and incentive programs, and actions taken in connection with local or global outbreaks of pandemics or contagious diseases or the fear of such outbreaks, such as the COVID-19 pandemic; risks inherent in marketing operations; credit risk; the availability of credit for customers; seasonality and industry cyclicality; potential delays or changes in plans with respect to capital expenditures; the cost and availability of sufficient financial resources to fund the Company’s capital expenditures; failure of the Company to realize the benefits of its operational excellence initiatives; incorrect assessments of the value of acquisitions, failure of the Company to realize the anticipated benefits of acquisitions, including to realize anticipated synergies and margin improvements, and the assumption of liabilities associated with acquisitions and/or the provision of indemnities to vendors in respect of any such assumed liabilities or otherwise; volatility in the stock markets including the market price of our securities; competition for, among other things, customers, supplies, acquisitions, capital and skilled personnel; the availability of capital on acceptable terms; dependence on suppliers; changes in labour costs and the labour market, including the risk of labour cost increases that may arise as a result of inflation and/or a scarcity of labour and/or labour activities; the impact of climate change and related laws and regulations; changes in trade relations between the countries in which the Company does business, including between Canada and the United States, including as a result of the tariffs imposed by the U.S., China and Canada on one another; cyber security risks; adjustments to and delays or cancellation of one or more orders comprising our order book; the requirement to re-supply equipment or re-complete work previously supplied or completed at AGI’s cost, and the risk that AGI’s assumptions and estimates made in respect of such costs and underlying the provision for warranty accrual in our consolidated financial statements related thereto and insurance coverage therefore will prove to be incorrect as further information becomes available to AGI; and the risk of litigation or unsuccessful defense of litigation in respect of equipment or work previously supplied or completed or in respect of other matters and the risk that AGI incurs material liabilities in connection with such litigation that are not covered by insurance in whole or in part. These risks and uncertainties are described under “Risks and Uncertainties” in the MD&A and in our most recently filed Annual Information Form, all of which are available under the Company’s profile on SEDAR+ [www.sedarplus.ca]. These factors should be considered carefully, and readers should not place undue reliance on the Company’s forward-looking information. We cannot assure readers that actual results will be consistent with this forward-looking information. Further, AGI cannot guarantee that the anticipated revenue from its order book will be realized or, if realized, will result in profits or Adjusted EBITDA. Delays, cancellations and scope adjustments occur from time-to-time with respect to contracts reflected in AGI’s order book, which can adversely affect the revenue and profit that AGI actually receives from its order book. Readers are further cautioned that the preparation of financial statements in accordance with IFRS requires management to make certain judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent liabilities. These estimates and related assumptions may change, having either a negative or positive effect on profit or loss, as further information becomes available and as the economic environment changes. Without limitation of the foregoing, the provisions for warranties disclosed in our MD&A required significant estimates, judgments and assumptions about the scope, nature, timing and cost of work that will be required. It is based on management’s estimates, judgments, and assumptions at the current date and is subject to revision in the future as further information becomes available to the Company. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information included in this press release is made as of the date of this press release and AGI undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless so required by applicable securities laws.
FINANCIAL OUTLOOK
Also included in this press release are estimates of AGI’s full-year 2025 Adjusted EBITDA and the potential impact that the tariffs imposed by the U.S., China and Canada on one another could have on our operations and financial results (including the direct cost impact of such tariffs on AGI in 2025), which are based on, among other things, the various assumptions disclosed in this press release, including under “Forward-Looking Information” and including our assumptions regarding the ability of AGI to convert AGI’s order book as of June 30, 2025 to revenue and Adjusted EBITDA during 2025 and the benefits of our operational excellence initiatives. To the extent such estimates constitute financial outlooks, they were approved by management on July 31, 2025, and are included to provide readers with an understanding of AGI’s anticipated full-year 2025 Adjusted EBITDA and the potential impact that the tariffs could have on our operations and financial results based on the assumptions described herein and readers are cautioned that the information may not be appropriate for other purposes. The financial outlooks disclosed herein do not include the potential impact of any tariff or other trade-related regulations enacted by the U.S., China, Canada or other countries other than those in effect as of July 31, 2025.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250731319154/en/
31 juli, 23:00
Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we”, or “our”) today announced its financial results for the three-month period ending June 30, 2025 and reiterated its previously stated outlook for full year 2025 Adjusted EBITDA.
Second Quarter 2025 Highlights
Outlook
“Our second quarter results reflect the continued strength of our international Commercial business, particularly in Brazil and EMEA4,” said Paul Householder, President and CEO of AGI. “While the North American Farm market remains soft, our diversification strategy and execution of long-term projects internationally have enabled us to deliver second quarter results towards the high-end of expectations. Our expanded capabilities that enable us to take on larger and more comprehensive projects has elevated enthusiasm about the potential of our international Commercial segment. Overall, with year-over-year revenue stabilizing in the second quarter, and significant strength in our Commercial order book, we anticipate returning to top-line growth in the second half of 2025. The outlook for the full year remains consistent though it has been updated to reflect additional strength in Commercial offset by continued softness in Farm, netting-out to unchanged full year Adjusted EBITDA guidance levels.”
“Amid the exciting opportunities in our international Commercial segment, we remain cognizant of the balance sheet and working capital implications,” said Jim Rudyk, CFO of AGI. “We are advancing structures to monetize receivables connected to our international Commercial projects which we expect to meaningfully reduce our working capital position and our net debt leverage ratio by year end. We are progressing through the usual process and steps to set up these kinds of arrangements and are targeting to finalize them in the third quarter. We’d like to thank all our partners for the support and cooperation to help make these significant projects a reality.”
1 Historical or forward-looking non-IFRS financial measure. See “Non-IFRS and Other Financial Measures”. |
- Second quarter 2025 profit before income taxes of $36.6 million. |
- Cash provided by operating activities of $30.7 million for LTM ended June 30, 2025. |
- Adjusted EBITDA for the year ended December 31, 2024 was $265 million. |
2 Historical or forward-looking non-IFRS ratio. See “Non-IFRS and Other Financial Measures”. |
3 Supplementary financial measure. See "Non-IFRS and Other Financial Measures". |
4 Europe, Middle East and Africa. |
SUMMARY OF SECOND QUARTER 2025 RESULTS
Revenue by Operating Segment | Three-months ended June 30 | |||
2025 | 2024 | Change | Change | |
[thousands of dollars except percentages] | $ | $ | $ | % |
Revenue[1] | ||||
Farm | 126,825 | 194,455 | (67,630) | (35%) |
Commercial | 221,735 | 157,326 | 64,409 | 41% |
Total | 348,560 | 351,781 | (3,221) | (1%) |
Adjusted EBITDA by Operating Segment | Three-months ended June 30 | |||
2025 | 2024 | Change | Change | |
[thousands of dollars except percentages] | $ | $ | $ | % |
Adjusted EBITDA[2] | ||||
Farm | 29,297 | 53,236 | (23,939) | (45%) |
Commercial | 36,803 | 23,248 | 13,555 | 58% |
Other [3] | (11,856) | (8,442) | (3,414) | N/A |
Total | 54,244 | 68,042 | (13,798) | (20%) |
Adjusted EBITDA Margin % by | Three-months ended June 30 | |||
2025 | 2024 | Change | Change | |
% | % | basis points | % | |
Adjusted EBITDA Margin % [2] | ||||
Farm | 23.1% | 27.4% | (428) bps | (16%) |
Commercial | 16.6% | 14.8% | 182 bps | 12% |
Other [3] | (3.4%) | (2.4%) | (100) bps | N/A |
Consolidated | 15.6% | 19.3% | (378) bps | (20%) |
Revenue by Geography [1] | Three-months ended June 30 | |||
[thousands of dollars except percentages] | 2025 | 2024 | Change | Change |
$ | $ | $ | % | |
Canada | 65,450 | 94,364 | (28,914) | (31%) |
U.S. | 112,824 | 146,366 | (33,542) | (23%) |
International | 170,286 | 111,051 | 59,235 | 53% |
Total Revenue | 348,560 | 351,781 | (3,221) | (1%) |
[1] | Supplementary financial measure. See "Non-IFRS and Other Financial Measures". | |
[2] | Non-IFRS financial measure or non-IFRS ratio. See "Non-IFRS and Other Financial Measures". | |
[3] | Included in Other is the corporate office, which is not a reportable segment, and which provides finance, treasury, legal, human resources and other administrative support to the segments and geographical regions, as applicable. The Adjusted EBITDA Margin % for Other is calculated based on total revenue since it does not generate revenue without the segments. | |
Order book
The following table presents YOY changes in the Company’s order book[1] as at June 30, 2025:
As at June 30 | ||||
[thousands of dollars except percentages] | 2025 | 2024[2] | Change | Change |
$ | $ | $ | % | |
Order book | 659,809 | 632,389 | 27,420 | 4% |
[1] | Supplementary financial measure. See "Non-IFRS and Other Financial Measures". | |
[2] | The order book as at June 30, 2024 has been revised to reflect orders that were outstanding at June 30, 2024 but that were subsequently cancelled. AGI originally reported an order book as at June 30, 2024 of $651 million. Revisions of this nature occur from time-to-time as part of normal business operations. | |
Second Quarter Farm Segment Summary
As anticipated, challenging conditions persisted across our Farm segment. U.S. and Canada, in particular, continue to face soft farmer demand given commodity prices below long-term averages as well as elevated dealer channel inventory levels which have yet to fully decline. These factors are compounded by shifting tariff policies and government subsidy uncertainty which create additional cautiousness across the entire farm equipment sector. Overall, Adjusted EBITDA Margin % remains compressed in the Farm segment relative to last year primarily due to lower volumes and, to a lesser extent, tariffs. Looking ahead, we anticipate near-term uncertainty for the North American Farm market to remain into the second half of 2025.
Second Quarter Commercial Segment Summary
Several long-term projects in our international regions in addition to stable U.S. activity drove strong growth across the Commercial segment. Brazil continues to successfully progress several large and comprehensive projects won in the second half of 2024 and the first half of 2025. The scale of the projects we are winning and the overall momentum in our international Commercial business highlight the broadening of our differentiated capabilities. Enabled by our product transfer program, we are able to deliver on nearly every aspect of these projects including a full scope of engineering, design, equipment supply, and installation services. Several notable projects won in the second quarter, in addition to a highly active quoting pipeline, create a solid outlook for continued momentum in our Commercial segment for the second half of the year and into early 2026.
MD&A and Financial Statements
AGI's unaudited interim condensed consolidated financial statements ("consolidated financial statements") and management’s discussion and analysis (the “MD&A”) for the three- and six-month periods ended June 30, 2025 can be obtained electronically on SEDAR+ (www.sedarplus.ca) and on AGI's website (www.aggrowth.com).
Conference Call
AGI will hold a conference call on Friday, August 1, 2025, at 8:00am ET to discuss its results for the three- and six-months ending June 30, 2025. To attend the event, please join using the AGI Second Quarter Results webcast link. Alternatively, participants can dial-in using +1-833-821-0159 if calling from Canada or the U.S. and +1-647-846-2271 internationally.
A replay of the webcast will be made available on AGI’s website. In addition, an audio replay of the call will be available for seven days. To access the audio replay, please dial +1-855-669-9658 if calling from Canada or the U.S. and +1-412-317-0088 internationally. Please enter access code 1863266# for the audio replay.
AGI Company Profile
AGI is a provider of the equipment and solutions required to support the efficient storage, transport, and processing of food globally. AGI has manufacturing facilities in Canada, the United States, Brazil, India, France, and Italy and distributes its product worldwide.
Further information can be found in the disclosure documents filed by AGI with the securities regulatory authorities, available at www.sedarplus.ca and on AGI's website www.aggrowth.com.
NON-IFRS AND OTHER FINANCIAL MEASURES
This press release makes reference to certain specified financial measures, including non-IFRS financial measures, non-IFRS ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and in analyzing our business performance and trends. These specified financial measures are not recognized measures under International Financial Reporting Standards (“IFRS”), do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement our financial information reported under IFRS by providing further understanding of our results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS.
We use the following (i) non-IFRS financial measures: “adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”)”, “free cash flow” and “net debt”; (ii) non-IFRS ratios: “Adjusted EBITDA margin %” and “net debt leverage ratio”; and (iii) supplementary financial measures: “order book”, “revenue by operating segment” and “revenue by geography”; to provide supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS financial measures, non-IFRS ratios and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. We strongly encourage investors to review our consolidated financial statements and publicly filed reports in their entirety and not to rely on any single financial measure or ratio.
We use these specified financial measures in addition to, and in conjunction with, results presented in accordance with IFRS. These specified financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our IFRS results and, in the case of non-IFRS financial measures, the accompanying reconciliations to the most directly comparable IFRS financial measures, may provide a more complete understanding of factors and trends affecting our business.
In this press release, we discuss the specified financial measures, including the reasons that we believe that these measures provide useful information regarding our financial condition, results of operations, cash flows and financial position, as applicable, and, to the extent material, the additional purposes, if any, for which these measures are used. Reconciliations of non-IFRS financial measures to the most directly comparable IFRS financial measures are contained in this press release.
The following is a list of non-IFRS financial measures, non-IFRS ratios and supplementary financial measures that are referenced throughout this press release:
“Adjusted EBITDA” is defined as income (loss) before income taxes before finance costs, depreciation and amortization, share of associate’s net income (loss), gain or loss on foreign exchange, non-cash share-based compensation expenses, net gain or loss on financial instruments, transaction, transitional and other costs (recovery), Enterprise Resource Planning system transformation costs, net gain or loss on sale of long-lived assets, equipment rework and remediation, accounts receivable reserve (recovery) for the conflict between Russia and Ukraine, and impairment charge (recovery). Adjusted EBITDA is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is profit (loss) before income taxes. Management believes Adjusted EBITDA is a useful measure to assess the performance and cash flow of the Company as it excludes the effects of interest, taxes, depreciation, amortization and expenses that management believes are not reflective of the Company’s underlying business performance. Management cautions investors that Adjusted EBITDA should not replace profit or loss as indicators of performance, or cash flows from operating, investing, and financing activities as a measure of the Company’s liquidity and cash flows. See “Profit (loss) before income taxes and Adjusted EBITDA” and “Profit (loss) before income taxes and Adjusted EBITDA by Operating Segment” below for the reconciliation of Adjusted EBITDA to profit (loss) before income taxes for the relevant periods. Adjusted EBITDA guidance is a forward-looking non-IFRS financial measure. We do not provide a reconciliation of such forward-looking measure to the most directly comparable financial measure calculated and presented in accordance with IFRS due to unknown variables and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. Guidance for Adjusted EBITDA is calculated in the same manner as described above for historical Adjusted EBITDA, as applicable.
“Adjusted EBITDA margin %” is defined as Adjusted EBITDA divided by revenue. Adjusted EBITDA margin % is a non-IFRS ratio because one of its components, Adjusted EBITDA, is a non-IFRS financial measure. Management believes Adjusted EBITDA margin % is a useful measure to assess the performance and cash flow of the Company.
“Free cash flow” is defined as cash provided (used) by operating activities less acquisition of property, plant and equipment and less development and purchase of intangible assets. Free cash flow is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is cash provided (used) by operating activities. Management believes that free cash flow provides useful information about the Company’s ability to generate available cash that can be used to fund ongoing and prospective strategic initiatives, reduce debt, or pursue other initiatives to enhance shareholder value after investing in capital expenditures that are required to maintain and grow the Company. Management uses free cash flow to help monitor the operational efficiency and financial flexibility of the Company. See “Free Cash Flow” below for a reconciliation of free cash flow to cash provided (used) by operating activities for the relevant periods.
“Order book” is defined as the total value of committed sales orders that have not yet been fulfilled that: (a) have a high certainty of being performed as a result of the existence of a purchase order, an executed contract or work order specifying job scope, value and timing; or (b) has been awarded to the Company or its divisions, as evidenced by an executed binding letter of intent or agreement, describing the general job scope, value and timing of such work, and where the finalization of a formal contract in respect of such work is reasonably assured. Order book is a supplementary financial measure.
“Revenue by Operating Segment” and “Revenue by Geography”: The revenue information presented under “Revenue by Operating Segment” and “Revenue by Geography” are supplementary financial measures used to present the Company’s revenue by segment and geography.
“Net Debt Leverage Ratio” is a non-IFRS ratio and is defined as net debt divided by Adjusted EBITDA for the last twelve-month (“LTM”) period. Net debt leverage ratio is a non-IFRS ratio because its components, net debt and Adjusted EBITDA, are non-IFRS financial measures. Management believes net debt leverage ratio is a useful measure to assess AGI’s leverage position.
“Net Debt” is a non-IFRS financial measure and its most directly comparable financial measure that is disclosed in our consolidated financial statements is long-term debt. Net debt is defined as the sum of long-term debt, convertible unsecured subordinated debentures, senior unsecured subordinated debentures, and lease liabilities less cash and cash equivalents. Management believes that net debt is a useful measure to evaluate AGI’s capital structure and to provide a measurement of AGI’s total indebtedness. See “Net Debt” below for a reconciliation of long-term debt to net debt for the relevant periods.
Profit (loss) before income taxes and Adjusted EBITDA
The following table reconciles profit (loss) before income taxes to Adjusted EBITDA.
Year ended December 31 | ||
[thousands of dollars] | 2024 | 2023 |
$ | $ | |
Profit (loss) before income taxes | (5,326) | 86,067 |
Finance costs | 70,242 | 73,667 |
Depreciation and amortization | 70,798 | 65,316 |
Share of associate's net income [1] | (109) | — |
Loss (gain) on foreign exchange [2] | 43,119 | (7,571) |
Share-based compensation [3] | 13,758 | 12,159 |
Net gain on financial instruments [4] | (3,812) | (5,369) |
Transaction, transitional and other costs [5] | 56,148 | 27,174 |
Enterprise Resource Planning (“ERP”) system transformation costs [6] | 17,271 | 14,001 |
Net loss on sale of long-lived assets [7] | 23 | 454 |
Equipment rework and remediation | — | 24,108 |
Accounts receivable reserve (recovery) for RUK | (268) | 1,651 |
Impairment charge [8] | 2,944 | 2,237 |
Adjusted EBITDA [9] | 264,788 | 293,894 |
[1] | See “Note 7 – Brazil investments” in our audited annual consolidated financial statements for the years ended December 31, 2024 and 2023 (the “2024 consolidated financial statements” and “2023 consolidated financial statements”). | |
[2] | See “Note 25[e] – Finance expenses (income)” in our 2024 consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 24 – Share-based compensation plans” in our 2024 consolidated financial statements. | |
[4] | See “Equity swap” in “Note 30 – Financial instruments and financial risk management” in our 2024 consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations, and other acquisition related transition costs as well as the accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | See “Note 11 – Property, plant and equipment” and “Note 16 – Assets held for sale” in our 2024 consolidated financial statements. | |
[8] | See “Impairment charge” in our 2024 consolidated financial statements. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Three-months ended June 30 | Six-months ended June 30 | |||
[thousands of dollars] | 2025 | 2024 | 2025 | 2024 |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 36,646 | (7,650) | 20,075 | (3,801) |
Finance costs | 17,213 | 17,060 | 33,806 | 36,011 |
Depreciation and amortization | 16,251 | 18,306 | 33,510 | 35,451 |
Share of associate's net income [1] | (640) | — | (498) | — |
Loss (gain) on foreign exchange [2] | (13,718) | 13,791 | (14,911) | 19,209 |
Share-based compensation [3] | 3,558 | 2,768 | 5,560 | 7,184 |
Net loss (gain) on financial instruments [4] | (3,181) | 3,812 | 3,426 | (4,004) |
Transaction, transitional and other costs (recovery) [5] | (6,284) | 11,929 | (2,567) | 16,379 |
ERP system transformation costs [6] | 4,208 | 4,925 | 7,005 | 9,050 |
Net loss (gain) on sale of long-lived assets [7] | 88 | 10 | 80 | (196) |
Accounts receivable recovery for RUK | — | — | — | (268) |
Impairment charge | 103 | 3,091 | 23 | 3,091 |
Adjusted EBITDA [8] | 54,244 | 68,042 | 85,509 | 118,106 |
[1] | See “Note 6 – Brazil investments” in our consolidated financial statements. | |
[2] | See “Note 13[e] – Finance expense (income)” in our consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Note 12 – Share-based compensation plans” in our consolidated financial statements. | |
[4] | See “Equity swap” in our consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. | |
[8] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Last Twelve-months ended June 30 | ||
[thousands of dollars] | 2025 | 2024 |
$ | $ | |
Profit (loss) before income taxes | 18,550 | 42,572 |
Finance costs | 68,037 | 73,660 |
Depreciation and amortization | 68,857 | 68,296 |
Share of associate’s net income [1] | (607) | — |
Loss on foreign exchange [2] | 8,692 | 20,788 |
Share-based compensation [3] | 12,134 | 13,037 |
Net loss (gain) on financial instruments [4] | 3,618 | (4,353) |
Transaction, transitional and other costs [5] | 37,202 | 30,829 |
ERP system transformation costs [6] | 15,226 | 23,051 |
Net loss on sale of long-lived assets [7] | 299 | 47 |
Remediation and rework | — | 3,600 |
Accounts receivable recovery for RUK | — | (350) |
Foreign exchange reclassification on disposal of foreign operation | 307 | — |
Impairment charge (recovery) [8] | (124) | 4,537 |
Adjusted EBITDA [9] | 232,191 | 275,714 |
[1] | See “Brazil Investments” in our consolidated financial statements and in our 2024 and 2023 consolidated financial statements. | |
[2] | See “Finance expenses (income)” in our consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Share-based compensation plans” in our consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[4] | See “Equity swap” in our consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations, and other acquisition related transition costs as well as the accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. See “Property, plant and equipment” and “Assets held for sale” in our 2024 and 2023 consolidated financial statements. | |
[8] | See “Impairment charge” in our 2024 and 2023 consolidated financial statements. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Last Twelve-months ended March 31 | ||
[thousands of dollars] | 2025 | 2024 |
$ | $ | |
Profit (loss) before income taxes | (25,746) | 68,290 |
Finance costs | 67,884 | 74,937 |
Depreciation and amortization | 70,912 | 66,421 |
Share of associate’s net loss [1] | 33 | — |
Loss on foreign exchange [2] | 36,508 | 464 |
Share-based compensation [3] | 11,344 | 12,307 |
Net loss on financial instruments [4] | 10,611 | 19 |
Transaction, transitional and other costs [5] | 55,415 | 27,695 |
ERP system transformation costs [6] | 15,943 | 18,126 |
Net loss on sale of long-lived assets [7] | 221 | 49 |
Remediation and rework | — | 24,108 |
Accounts receivable reserve for RUK | — | 1,383 |
Impairment charge [8] | 2,864 | 2,047 |
Adjusted EBITDA [9] | 245,989 | 295,846 |
[1] | See “Brazil Investments” in our unaudited interim condensed consolidated financial statements for the three-month period ended March 31, 2025 (the “2025 Q1 consolidated financial statements”) and in our 2024 consolidated financial statements. | |
[2] | See “Finance expenses (income)” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[3] | The Company’s share-based compensation expense pertains to our equity incentive award plan (“EIAP”) and directors’ deferred compensation plan (“DDCP”). See “Share-based compensation plans” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[4] | See “Equity swap” in our 2025 Q1 consolidated financial statements, 2024 and 2023 consolidated financial statements. | |
[5] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations, and other acquisition related transition costs as well as the accretion and other movement in amounts due to vendors. | |
[6] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[7] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. See “Property, plant and equipment” and “Assets held for sale” in our 2024 and 2023 consolidated financial statements. | |
[8] | See “Impairment charge” in our 2024 and 2023 consolidated financial statements. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
Profit (loss) before income taxes and Adjusted EBITDA by Operating Segment
The following tables reconcile profit (loss) before income taxes to Adjusted EBITDA by operating segment for the applicable periods.
Three-months ended June 30, 2025 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 22,329 | 29,812 | (15,495) | 36,646 |
Finance costs | — | — | 17,213 | 17,213 |
Depreciation and amortization [1] | 6,475 | 7,640 | 2,136 | 16,251 |
Share of associate's net income [2] | — | (640) | — | (640) |
Gain on foreign exchange [3] | — | — | (13,718) | (13,718) |
Share-based compensation [4] | — | — | 3,558 | 3,558 |
Net gain on financial instruments [5] | — | — | (3,181) | (3,181) |
Transaction, transitional and other costs (recovery) [6] | 428 | — | (6,712) | (6,284) |
ERP system transformation costs [7] | — | — | 4,208 | 4,208 |
Net loss (gain) on sale of long-lived assets [1] [8] | (38) | (9) | 135 | 88 |
Impairment charge | 103 | — | — | 103 |
Adjusted EBITDA [9] | 29,297 | 36,803 | (11,856) | 54,244 |
Three-months ended June 30, 2024 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 38,193 | 14,910 | (60,753) | (7,650) |
Finance costs | — | — | 17,060 | 17,060 |
Depreciation and amortization [1] | 7,889 | 8,581 | 1,836 | 18,306 |
Loss on foreign exchange [3] | — | — | 13,791 | 13,791 |
Share-based compensation [4] | — | — | 2,768 | 2,768 |
Net loss on financial instruments [5] | — | — | 3,812 | 3,812 |
Transaction, transitional and other costs [6] | 3,785 | — | 8,144 | 11,929 |
ERP system transformation costs [7] | — | — | 4,925 | 4,925 |
Net loss (gain) on sale of long-lived assets [1] [8] | 355 | (320) | (25) | 10 |
Impairment charge | 3,014 | 77 | — | 3,091 |
Adjusted EBITDA [9] | 53,236 | 23,248 | (8,442) | 68,042 |
Six-months ended June 30, 2025 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 32,884 | 46,304 | (59,113) | 20,075 |
Finance costs | — | — | 33,806 | 33,806 |
Depreciation and amortization [1] | 13,981 | 15,505 | 4,024 | 33,510 |
Share of associate's net income [2] | — | (498) | — | (498) |
Gain on foreign exchange [3] | — | — | (14,911) | (14,911) |
Share-based compensation [4] | — | — | 5,560 | 5,560 |
Net loss on financial instruments [5] | — | — | 3,426 | 3,426 |
Transaction, transitional and other costs (recovery) [6] | 1,607 | — | (4,174) | (2,567) |
ERP system transformation costs [7] | — | — | 7,005 | 7,005 |
Net loss (gain) on sale of long-lived assets [1] [8] | (21) | (22) | 123 | 80 |
Impairment charge | 23 | — | — | 23 |
Adjusted EBITDA [9] | 48,474 | 61,289 | (24,254) | 85,509 |
Six-months ended June 30, 2024 | ||||
[thousands of dollars] | Farm | Commercial | Other [10] | Total |
$ | $ | $ | $ | |
Profit (loss) before income taxes | 76,451 | 20,064 | (100,316) | (3,801) |
Finance costs | — | — | 36,011 | 36,011 |
Depreciation and amortization [1] | 14,853 | 16,907 | 3,691 | 35,451 |
Loss on foreign exchange [3] | — | — | 19,209 | 19,209 |
Share-based compensation [4] | — | — | 7,184 | 7,184 |
Net gain on financial instruments [5] | — | — | (4,004) | (4,004) |
Transaction, transitional and other costs [6] | 3,785 | — | 12,594 | 16,379 |
ERP system transformation costs [7] | — | — | 9,050 | 9,050 |
Net loss (gain) on sale of long-lived assets [1] [8] | 141 | (314) | (23) | (196) |
Accounts receivable recovery for RUK | — | (268) | — | (268) |
Impairment charge | 3,014 | 77 | — | 3,091 |
Adjusted EBITDA [9] | 98,244 | 36,466 | (16,604) | 118,106 |
[1] | Allocated based on the segment of the underlying asset’s cash generating unit (“CGU”). | |
[2] | See “Note 6 – Brazil investments” in our consolidated financial statements. | |
[3] | See “Note 13[e] – Finance expense (income)” in our consolidated financial statements. | |
[4] | The Company’s share-based compensation expense pertains to our EIAP and DDCP. See “Note 12 – Share-based compensation plans” in our consolidated financial statements. | |
[5] | See “Equity swap” in our consolidated financial statements. | |
[6] | Includes legal and advisory fees, legal provision, transitional costs related to reorganizations and other acquisition related transition costs, as well as the accretion and other movement in amounts due to vendors. | |
[7] | Expenses incurred in connection with a global multi-year ERP transformation project. | |
[8] | Includes gain/loss on sale of property, plant, equipment, assets held for sale, and settlement of lease liabilities. | |
[9] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure. | |
[10] | Included in Other is the corporate office, which is not a reportable segment, and which provides finance, treasury, legal, human resources and other administrative support to the segments. | |
Net Debt
The following table reconciles long term debt to net debt as at June 30, 2025 and 2024 and March 31, 2025.
Q2/25 | Q1/25 | Q2/24 | |
[thousands of dollars] | 30-Jun-25 | 31-Mar-25 | 30-Jun-24 |
Long Term Debt | 528,785 | 639,896 | 523,727 |
Convertible Unsecured Subordinated Debentures | 200,688 | 198,837 | 193,479 |
Senior Unsecured Subordinated Debentures | 177,392 | 84,085 | 169,559 |
Leases | 45,224 | 46,705 | 46,054 |
Less: Cash & Cash Equivalents | 47,527 | 76,951 | 85,909 |
Net Debt | 904,562 | 892,572 | 846,910 |
Free Cash Flow
The following table reconciles cash provided (used) by operating activities to free cash flow for the applicable periods.
Last Twelve-months ended June 30 | ||
2025 | 2024 | |
[thousands of dollars] | $ | $ |
Cash provided by operating activities | 30,737 | 118,510 |
Less: acquisition of property, plant and equipment | (20,110) | (44,970) |
Less: development and acquisition of intangibles | (10,293) | (8,681) |
Free cash flow [1] | 334 | 64,859 |
[1] | This is a non-IFRS measure and is used throughout this press release. See “NON-IFRS AND OTHER FINANCIAL MEASURES” for more information on each non-IFRS measure | |
FORWARD-LOOKING INFORMATION
This press release contains forward-looking statements and information [collectively, “forward-looking information”] within the meaning of applicable securities laws that reflect our expectations regarding the future growth, results of operations, performance, business prospects, and opportunities of the Company. All information and statements contained herein that are not clearly historical in nature constitute forward-looking information, and the words “anticipate”, “estimate”, “believe”, “continue”, “could”, “expects”, “intend”, “trend”, “plans”, “will”, “may” or similar expressions suggesting future conditions or events or the negative of these terms are generally intended to identify forward-looking information. Forward-looking information involves known or unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. In addition, this press release may contain forward-looking information attributed to third party industry sources. Undue reliance should not be placed on forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which it is based will occur. In particular, the forward-looking information in this press release includes information relating to: our Adjusted EBITDA guidance for full year 2025; our belief that the increase in our order book is supported by significant growth within our international Commercial businesses; our belief that our current Commercial order book is strong and provides visibility for the remainder of 2025; our belief that Farm segment visibility for the second half of 2025 remains limited due to challenging market conditions; that based on current tariff policies and regulations, we estimate a relatively minor direct cost impact to AGI in 2025; our beliefs regarding the continued strength of our international Commercial business, particularly in Brazil and EMEA; our beliefs that our expanded capabilities enable us to take-on larger and more comprehensive projects and has elevated enthusiasm about the potential of our international Commercial segment; our expectations that we will return to top-line growth across the second half of 2025 as a result of year-over-year revenue stabilizing across Q2, and significant strength in our Commercial order book; our beliefs regarding our overall outlook for full year 2025; our expectations that we will be able to meaningfully reduce our working capital position and our leverage ratio; our expectations regarding the challenging conditions in our Farm segment, particularly in the U.S. and Canada, with respect to soft farmer demand given commodity prices below long-term averages putting pressure on farmer income, and elevated dealer inventory levels; our expectations regarding Adjusted EBITDA Margin % in the Farm segment; our expectations that near-term uncertainty for the North American Farm market to remain into the second half of the year; our expectations regarding several large and comprehensive projects in Brazil, including that such project wins underscore the broadening of our capabilities to be able to execute the construction of comprehensive and dynamic facilities; our belief that we are able to deliver on nearly every aspect of these projects including a full scope of engineering, design, equipment supply, and installation services; and our expectations regarding the overall momentum in our international Commercial business.
Such forward-looking information reflects our current beliefs and is based on information currently available to us, including certain key expectations and assumptions concerning: the duration and impact of tariffs that are currently in effect on goods exported from or imported into Canada, and that other than the tariffs that are currently in effect, neither the U.S., China nor Canada (i) increases the rate or scope of such tariffs, reenacts tariffs that are currently suspended, or imposes new tariffs, on the import of goods from one country to the other, including on the products that AGI imports or exports and/or (ii) imposes any other form of tax, restriction, or prohibition on the import or export of products from one country to the other, including on the products that AGI imports or exports; anticipated crop yields and production in our market areas; the financial and operating attributes of acquired businesses and the anticipated future performance thereof; the value of acquired businesses and assets and the liabilities assumed (and indemnities provided) by AGI in connection therewith; anticipated financial performance; future debt levels; business prospects and strategies, including the success of our operational excellence initiatives; product and input pricing; the scope, nature, timing and cost of re-supplying certain equipment and re-completing certain work that has previously been supplied or completed pursuant to warranty obligations or otherwise; regulatory developments; tax laws; the sufficiency of budgeted capital expenditures in carrying out planned activities; currency exchange rates, inflation rates and interest rates; the cost of materials, labour and services and the impact of inflation rates and/or supply chain disruptions and/or labour activity thereon; the impact of competition; the general stability of the economic and regulatory environments in which the Company operates; the timely receipt of any required regulatory and third party approvals; the ability of the Company to obtain and retain qualified staff and services in a timely and cost efficient manner; the amount and timing of the dividends that we expect to pay; the amount of funds that we expect to invest in the repurchase of our common shares under our normal course issuer bid and the timing thereof; the ability of the Company to obtain financing on acceptable terms; the regulatory framework in the jurisdictions in which the Company operates; the ability of the Company to successfully market its products and services; and that a pandemic or other public health emergency will not have a material impact on our business, operations, and financial results going forward.
Forward-looking information involves significant risks and uncertainties. A number of factors could cause actual results to differ materially from results discussed in the forward-looking information. These risks and uncertainties include but are not limited to the following: the risk that (i) the tariffs that are currently in effect on goods exported from or imported into Canada continue in effect for an extended period of time, the tariffs that have been threatened are implemented, that tariffs that are currently suspended are reactivated, the rate or scope of existing tariffs are increased or expanded, or new tariffs are imposed, including on products that AGI exports or imports, (ii) the U.S., China and/or Canada imposes any other form of tax, restriction or prohibition on the import or export of products from one country to the other, including on products that AGI exports or imports, and (iii) the tariffs imposed or threatened to be imposed by the U.S. on other countries and retaliatory tariffs imposed or threatened to be imposed by other countries on the U.S., will trigger a broader global trade war which could have a material adverse effect on the Canadian, U.S. and global economies, and by extension the Canadian, U.S. and international agricultural industry and AGI, including by decreasing demand for (and the price of) AGI’s products, disrupting supply chains, increasing costs, causing volatility in global financial markets, and limiting access to financing; general economic and business conditions and changes in international, national and local macroeconomic and business conditions, as well as sociopolitical conditions in certain local or regional markets, including as a result of conflicts in the Middle East and the conflict between Russia and Ukraine and the responses thereto from other countries and institutions (including trade sanctions and financial controls), which has created volatility in the global economy and could continue to adversely impact economic and trade activity; the effects of global outbreaks of pandemics or contagious diseases or the fear of such outbreaks, such as the coronavirus (COVID-19) pandemic; the ability of management to execute the Company’s business plan; fluctuations in agricultural and other commodity prices, interest rates, inflation rates and currency exchange rates; crop planting, crop conditions and crop yields; weather patterns; the timing of harvest and conditions during harvest; volatility of production costs, including the risk of production cost increases that may arise as a result of inflation and/or supply chain disruptions and/or labour actions, and the risk that we may not be able to pass along all or any portion of increased costs to customers; governmental regulation of the agriculture and manufacturing industries, including environmental and climate change regulation; actions taken by governmental authorities, including increases in taxes, changes in government regulations and incentive programs, and actions taken in connection with local or global outbreaks of pandemics or contagious diseases or the fear of such outbreaks, such as the COVID-19 pandemic; risks inherent in marketing operations; credit risk; the availability of credit for customers; seasonality and industry cyclicality; potential delays or changes in plans with respect to capital expenditures; the cost and availability of sufficient financial resources to fund the Company’s capital expenditures; failure of the Company to realize the benefits of its operational excellence initiatives; incorrect assessments of the value of acquisitions, failure of the Company to realize the anticipated benefits of acquisitions, including to realize anticipated synergies and margin improvements, and the assumption of liabilities associated with acquisitions and/or the provision of indemnities to vendors in respect of any such assumed liabilities or otherwise; volatility in the stock markets including the market price of our securities; competition for, among other things, customers, supplies, acquisitions, capital and skilled personnel; the availability of capital on acceptable terms; dependence on suppliers; changes in labour costs and the labour market, including the risk of labour cost increases that may arise as a result of inflation and/or a scarcity of labour and/or labour activities; the impact of climate change and related laws and regulations; changes in trade relations between the countries in which the Company does business, including between Canada and the United States, including as a result of the tariffs imposed by the U.S., China and Canada on one another; cyber security risks; adjustments to and delays or cancellation of one or more orders comprising our order book; the requirement to re-supply equipment or re-complete work previously supplied or completed at AGI’s cost, and the risk that AGI’s assumptions and estimates made in respect of such costs and underlying the provision for warranty accrual in our consolidated financial statements related thereto and insurance coverage therefore will prove to be incorrect as further information becomes available to AGI; and the risk of litigation or unsuccessful defense of litigation in respect of equipment or work previously supplied or completed or in respect of other matters and the risk that AGI incurs material liabilities in connection with such litigation that are not covered by insurance in whole or in part. These risks and uncertainties are described under “Risks and Uncertainties” in the MD&A and in our most recently filed Annual Information Form, all of which are available under the Company’s profile on SEDAR+ [www.sedarplus.ca]. These factors should be considered carefully, and readers should not place undue reliance on the Company’s forward-looking information. We cannot assure readers that actual results will be consistent with this forward-looking information. Further, AGI cannot guarantee that the anticipated revenue from its order book will be realized or, if realized, will result in profits or Adjusted EBITDA. Delays, cancellations and scope adjustments occur from time-to-time with respect to contracts reflected in AGI’s order book, which can adversely affect the revenue and profit that AGI actually receives from its order book. Readers are further cautioned that the preparation of financial statements in accordance with IFRS requires management to make certain judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, income and expenses and the disclosure of contingent liabilities. These estimates and related assumptions may change, having either a negative or positive effect on profit or loss, as further information becomes available and as the economic environment changes. Without limitation of the foregoing, the provisions for warranties disclosed in our MD&A required significant estimates, judgments and assumptions about the scope, nature, timing and cost of work that will be required. It is based on management’s estimates, judgments, and assumptions at the current date and is subject to revision in the future as further information becomes available to the Company. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information included in this press release is made as of the date of this press release and AGI undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless so required by applicable securities laws.
FINANCIAL OUTLOOK
Also included in this press release are estimates of AGI’s full-year 2025 Adjusted EBITDA and the potential impact that the tariffs imposed by the U.S., China and Canada on one another could have on our operations and financial results (including the direct cost impact of such tariffs on AGI in 2025), which are based on, among other things, the various assumptions disclosed in this press release, including under “Forward-Looking Information” and including our assumptions regarding the ability of AGI to convert AGI’s order book as of June 30, 2025 to revenue and Adjusted EBITDA during 2025 and the benefits of our operational excellence initiatives. To the extent such estimates constitute financial outlooks, they were approved by management on July 31, 2025, and are included to provide readers with an understanding of AGI’s anticipated full-year 2025 Adjusted EBITDA and the potential impact that the tariffs could have on our operations and financial results based on the assumptions described herein and readers are cautioned that the information may not be appropriate for other purposes. The financial outlooks disclosed herein do not include the potential impact of any tariff or other trade-related regulations enacted by the U.S., China, Canada or other countries other than those in effect as of July 31, 2025.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250731319154/en/
Handelskrig
Apple
Analys
Handelskrig
Apple
Analys
1 DAG %
Senast
Handelskrig
1 augusti, 15:51
Professorn: "Svårt att tänka sig en guldålder"
Kempower
1 augusti, 12:28
Laddat för tillväxt i Kempower
Novo Nordisk
1 augusti, 10:47
1000 miljarder utraderade i Novo Nordisk
OMX Stockholm 30
1 DAG %
Senast
2 533,59